Clinical Trials
Study Title:
A Dose Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single Agent and Combination Therapy in Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
|
For more information about the trial above please contact the study team:
|